Divergent Effects of α -Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype
Authors:
- 15 January 2010
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 12 (2) , 209-217
Abstract
The haptoglobin (Hp) 2-2 genotype is associated with increased risk of cardiovascular disease (CVD) in diabetes (DM). We recently proposed this increased risk arises from the tethering of redox active hemoglobin (Hb) to high density lipoprotein (HDL), thereby resulting in oxidative modification of HDL. Clinical trials have demonstrated that vitamin E (α-tocopherol) decreases while vitamin C increases CVD in Hp 2-2 DM individuals. We sought to test the hypothesis that the interaction of α-tocopherol or vitamin C on CVD in Hp 2-2 DM was due to their divergent effects on HDL oxidation and function. Vitamin C significantly increased while α-tocopherol completely blocked oxidation mediated by glycosylated Hb-Hp 2-2. Vitamin C had no benefit while α-tocopherol completely restored HDL function in Hp 2-2 DM mice. Co-administration of vitamin C mitigated the protective effects of α-tocopherol on HDL. There exists a pharmacogenomic interaction between vitamin C and α-tocopherol and the Hp 2-2 genotype on HDL function and structure. Choosing the correct antioxidant in the correct subset of patients may be critical in order to demonstrate benefit from antioxidant therapy. Antioxid. Redox Signal. 12, 209–218.Keywords
This publication has 41 references indexed in Scilit:
- Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 GenotypeDiabetes, 2008
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In VivoCirculation Research, 2006
- Haptoglobin Phenotypes Differ in Their Ability To Inhibit Heme Transfer from Hemoglobin to LDLBiochemistry, 2004
- Iron toxicity and antioxidant nutrientsToxicology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Structure-function analysis of the antioxidant properties of haptoglobinBlood, 2001
- Beyond CholesterolNew England Journal of Medicine, 1989
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patientsBiochemical Medicine, 1983